1007875-19-5Relevant academic research and scientific papers
Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis
Lu, Xiaoyun,Tang, Jian,Liu, Zhiyong,Li, Minke,Zhang, Tianyu,Zhang, Xiantao,Ding, Ke
, p. 5916 - 5919 (2016)
A series of biheterocyclic (1H-indole, benzofuran, pyrazolo[1,5-a]pyrimidine, pyrazolo[1,5-a]pyrimidin-5(4H)-one, imidazo[2,1-b]thiazole and pyrazolo[5,1-b]thiazole) derivatives were synthesized and evaluated for their anti-tubercular activities. The imid
BENZYL AMINE-CONTAINING HETEROCYCLIC COMPOUNDS AND COMPOSITIONS USEFUL AGAINST MYCOBACTERIAL INFECTION
-
Page/Page column 49, (2017/04/11)
Described herein are compounds and compositions, and methods of making and their use as effective agents against mycobacterial infections.
5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS
-
Paragraph 0216; 0237; 0238; 0246; 0256, (2016/10/10)
The invention provides a series of 5,5-heteroaromatic compounds, syntheses thereof, compositions thereof, and methods of using such compounds and compositions. Various embodiments provide methods of killing and/or inhibiting the growth of M. tuberculosis
5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS
-
Paragraph 0167, (2015/08/04)
The invention provides a series of 5,5-heteroaromatic compounds, syntheses thereof, compositions thereof, and methods of using such compounds and compositions. Various embodiments provide methods of killing and/or inhibiting the growth of M. tuberculosis
3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 45, (2010/02/17)
The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 81, (2009/03/07)
The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
